Page last updated: 2024-08-21

dihydroergotamine and ketorolac

dihydroergotamine has been researched along with ketorolac in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's2 (18.18)29.6817
2010's5 (45.45)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Klapper, JA; Stanton, JS1
Kumar, KL1
Landy, S; Lobo, BL1
Berger, MY; Bruijn, JK; Damen, L; Koes, BW; Passchier, J; Verhagen, AP1
Friedman, BW; Friedman, MS; Hochberg, ML; Kapoor, A; Rowe, BH1
Gerard, JM; Kaar, CR; Nakanishi, AK1
Hershey, AD; Kabbouche, M; Maconochie, I; Murphy, B; Qaiser, S; Werner, K1

Reviews

5 review(s) available for dihydroergotamine and ketorolac

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advances in the acute management of migraine and cluster headaches.
    Journal of general internal medicine, 1994, Volume: 9, Issue:6

    Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin

1994
Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Pediatrics, 2005, Volume: 116, Issue:2

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Controlled Clinical Trials as Topic; Dihydroergotamine; Female; Humans; Ibuprofen; Ketorolac; Male; Migraine Disorders; Prochlorperazine; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan

2005
The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials.
    Annals of emergency medicine, 2008, Volume: 52, Issue:6

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Humans; Ketorolac; Meperidine; Migraine Disorders; Randomized Controlled Trials as Topic

2008
Intravenous Migraine Treatment in Children and Adolescents.
    Current pain and headache reports, 2020, Jul-08, Volume: 24, Issue:8

    Topics: Administration, Intravenous; Adolescent; Akathisia, Drug-Induced; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Basal Ganglia Diseases; Child; Dexamethasone; Dihydroergotamine; Diphenhydramine; Dopamine Antagonists; Emergency Service, Hospital; Enzyme Inhibitors; Fluid Therapy; Glucocorticoids; Hospitalization; Humans; Hypnotics and Sedatives; Ketorolac; Lidocaine; Magnesium; Migraine Disorders; Prochlorperazine; Propofol; Valproic Acid; Vasoconstrictor Agents

2020

Other Studies

6 other study(ies) available for dihydroergotamine and ketorolac

ArticleYear
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches.
    Headache, 1991, Volume: 31, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Drug Therapy, Combination; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Tolmetin

1991
Recommendations for the emergency treatment of migraine headache.
    Journal of the Tennessee Medical Association, 1994, Volume: 87, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dexamethasone; Dihydroergotamine; Emergency Medical Services; Humans; Ketorolac; Migraine Disorders; Sumatriptan; Tolmetin

1994
The Use of a Pediatric Migraine Practice Guideline in an Emergency Department Setting.
    Pediatric emergency care, 2016, Volume: 32, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dihydroergotamine; Diphenhydramine; Emergency Service, Hospital; Female; Guideline Adherence; Humans; Hypnotics and Sedatives; Ketorolac; Length of Stay; Male; Metoclopramide; Migraine Disorders; Pain Management; Pain Measurement; Practice Guidelines as Topic; Prochlorperazine; Treatment Outcome; Vasoconstrictor Agents

2016